Dolby Laboratories Q3 2024 Adj. EPS $0.71 Beats $0.59 Estimate, Sales $288.818M Beat $286.183M Estimate
Portfolio Pulse from Benzinga Newsdesk
Dolby Laboratories (NYSE:DLB) reported Q3 2024 adjusted EPS of $0.71, beating the analyst estimate of $0.59 by 20.34%. Sales were $288.818 million, surpassing the $286.183 million estimate by 0.92%, but down 3.20% from the same period last year.
August 07, 2024 | 8:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Dolby Laboratories reported Q3 2024 adjusted EPS of $0.71, beating the analyst estimate of $0.59 by 20.34%. Sales were $288.818 million, surpassing the $286.183 million estimate by 0.92%, but down 3.20% from the same period last year.
Dolby Laboratories' better-than-expected EPS and sales figures are likely to positively impact the stock price in the short term, despite the year-over-year sales decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100